✦ LIBER ✦

Dalteparin in combination with abciximab during percutaneous coronary intervention

✍ Scribed by Dean J. Kereiakes; Neal S. Kleiman; Edward Fry; Grace Mwawasi; Rose Lengerich; Kelly Maresh; Mary Lynn Burkert; Joseph W. Aquilina; Michael DeLoof; Thomas M. Broderick; Thomas M. Shimshak

Book ID: 117842383
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 100 KB
Volume: 141
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2001.113217

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switch from abciximab to eptifibatide du

Switch from abciximab to eptifibatide during percutaneous coronary intervention

✍ Magnus Wahlin; Per Albertsson; Thomas Karlsson; Göran Matejka; Annika Odell; Far 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Safety of abciximab during percutaneous

Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency

✍ Allen Jeremias; Deepak L. Bhatt; Derek P. Chew; Khaled M. Ziada; Abdulhay Albiri 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Leukocyte-platelet aggregation, platelet

Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab

✍ Mark I. Furman; Dean J. Kereiakes; Lori A. Krueger; Michele N. Mueller; Karen Pi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 219 KB

A randomized pilot study of dalteparin v

A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions

✍ Madhu K. Natarajan; James L. Velianou; Alexander G.G. Turpie; Shamir R. Mehta; D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Predictors of Bleeding Complications and

Predictors of Bleeding Complications and Thrombocytopenia with the Use of Abciximab during Percutaneous Coronary Intervention

✍ OMAR ABDUL RAZAKJR; HUAY CHEEM TAN; WEI LUEN YIP; YEAN TENG LIM 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

One-Year Outcomes With Abciximab vs. Pla

One-Year Outcomes With Abciximab vs. Placebo During Percutaneous Coronary Intervention After Pre-treatment With Clopidogrel

✍ A. Schomig; C. Schmitt; A. Dibra 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 30 KB